echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Inflammation has triggered new clues to Alzheimer's disease

    Inflammation has triggered new clues to Alzheimer's disease

    • Last Update: 2023-02-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
      

    Scientists at the University of Texas San Antonio Health Sciences Center (UT Health SAN ANTONIO) reported today that inflammatory triggers present during viral infections are elevated
    in Alzheimer's disease and progressive supranuclear palsy, a rare brain disease.

    Study author Elizabeth Ochoa of the University of Texas Health Center in San Antonio said: "We have identified new triggers of brain inflammation in these diseases
    .
    " For this reason, she said, the discovery, published in Science Advances
    , is novel.

    Alzheimer's disease and progressive supranuclear palsy are characterized by toxic deposits of a protein called tau
    .
    Their research found that tau-induced "jumping genes" — which can relocate or replicate themselves to other locations in the genome — form double-stranded RNA
    .
    This abnormal RNA mimics the inflammatory triggers
    that are also present in viral infections.

    "Transposable factors — so-called jumping genes — are a new area
    of interest in understanding Alzheimer's disease.
    Our research provides new insights
    into how they can drive disease progression beyond their ability to jump.
    To the immune system, these double-stranded RNAs look like viruses, even though jumping genes are part of
    our normal genome.

    The researchers detected the accumulation
    of double-stranded RNA in postmortem brain tissue in patients with Alzheimer's disease and progressive supranuclear palsy, as well as in the brains of mouse and tau disease fruit fly models.

    "We found a large number of deposits of double-stranded RNA in astrocytes that provide metabolic support to neurons, regulate neurotransmitters, and maintain the integrity
    of the blood-brain barrier.
    " "In aging and disease, astrocytes respond to
    damage and disruption of the neuronal environment.
    Our findings open new doors
    to understanding astrocyte biology and its role in transposable factor control.

    In Alzheimer's and other neurodegenerative diseases, the loss of neurons (cells of the central nervous system) is gradual
    .

    The researchers conducted experiments on fruit flies to quickly test their questions
    about double-stranded RNA and inflammation in the brain.
    "To make sure that what we found in fruit fly experiments is related to mammalian disease, we also looked at mouse models and brain tissue
    from postmortem human brains affected by mizoaur disease," Ochoa said.

    "Since we are currently targeting jumping gene activation in local phase II clinical trials for Alzheimer's disease patients, it is important
    to understand the full arsenal of toxic molecules, including double-stranded RNA, produced by jumping genes.
    "

    essay

    Pathogenic tau–induced transposable element–derived dsRNA drives neuroinflammation


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.